Pfizer Inc., 10% Owner at ENCYSIVE PHARMACEUTICALS INC (ENCY), bought 2,385,833 shares at $2.35 ($5.6M) on 2008-04-04, disclosed to the SEC on 2008-04-07.
Open-market purchase of $5.6M ENCY by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.35 | 1,809,663 | $4.3M | 75.9% |
| 2 | $2.35 | 576,170 | $1.4M | 24.1% |
| Total | $2.35 avg | 2,385,833 | $5.6M | 100% |
| Filing → |
| SWTX | BUY | 2019-09-19 | $900K | — | Filing → |
| ALLO | BUY | 2018-10-17 | $1.0M | — | Filing → |
| RYTM | BUY | 2017-10-10 | $680K | — | Filing → |